Table 2.
Demographic, clinical, biochemical and angiographic characteristics in low and intermediate-high SYNTAX score (SS) group
| Variables | SS ≤ 22 (n = 168) | SS > 22 (n = 33) | P value |
|---|---|---|---|
| Age, years | 65 (57–71) | 63 (58–75) | .304 |
| Male gender, n (%) | 114 (67.9%) | 22 (66.7%) | .894 |
| Hypertension, n (%) | 107 (63.7%) | 20 (60.6%) | .737 |
| Diabetes, n (%) | 40 (23.8%) | 9 (27.3%) | .672 |
| Smoking, n (%) | 25 (14.9%) | 5 (15.2%) | .968 |
| BMI, kg/m2 | 24.9 ± 3.5 | 24.2 ± 2.7 | .312 |
| WBC, 109/L | 6.6 (5.3–8.0) | 7.0 (5.6–8.8) | .210 |
| NEUT, 109/L | 4.1 (3.3–5.4) | 4.5 (3.6–5.9) | .231 |
| LYM, 109/L | 1.7 (1.3–2.1) | 1.9 (1.3–2.2) | .833 |
| NLR | 2.4 (1.8–3.4) | 2.6 (2.0–3.6) | .277 |
| Platelet, 109/L | 174 (141–212) | 185 (145–225) | .275 |
| RDW | 12.9 (12.5–13.3) | 12.8 (12.5–13.4) | .741 |
| Hemoglobin, g/L | 129.8 ± 14.6 | 128.1 ± 23.7 | .597 |
| IL-6, pg/ml | 6.5 (4.3–9.2) | 14.0 (11.1–24.8) | < .001 |
| hs-CRP, mg/l | 4.5 (1.3–9.0) | 11.8 (8.7–20.0) | < .001 |
| Glucose, mmol/L | 5.7 ± 2.5 | 5.6 ± 1.4 | .830 |
| TC, mmol/L | 3.9 ± 1.0 | 4.0 ± 1.0 | .578 |
| Triglyceride, mmol/L | 1.4 (1.0–2.0) | 1.6 (1.2–1.8) | .409 |
| HDL-c, mmol/L | 1.2 (1.1–1.4) | 1.1 (1.0–1.3) | .187 |
| LDL-c, mmol/L | 2.2 ± 0.8 | 2.4 ± 0.9 | .176 |
| apoB, g/L | 0.8 (0.6–0.9) | 0.9 (0.6–1.1) | .138 |
| apoA1, g/L | 1.0 ± 0.2 | 1.1 ± 0.2 | .571 |
| Creatinine, umol/L | 69.4 (57.7–85.2) | 68.5 (57.2–87.6) | .984 |
| eGFR, ml/min | 86.3 (67.4–113.1) | 86.1 (66.8–104.2) | .570 |
| Albumin, g/L | 39.4 (37.5–41.5) | 38.6 (35.9–40.6) | .091 |
| Fibrinogen, g/L | 3.0 (2.6–3.8) | 3.4 (2.8–4.0) | .129 |
| D-Dimer, ug/ml | 0.3 (0.2–0.5) | 0.4 (0.2–0.6) | .400 |
| LVEF, % | 62.0 (58.0–65.0) | 62.0 (53.0–65.0) | .744 |
| SS | 12.0 (7.0–15.8) | 26.0 (23.5–28.5) | < .001 |
| SS II | 24.5 (19.9–31.3) | 30.5 (24.5–37.5) | .001 |
| rSS | 2.0 (0–5.0) | 10.0 (4.0–16.8) | < .001 |
BMI, Body Mass Index; WBC, white blood cell; NEUT, neutrophil; LYM, lymphocyte; NLR, the neutrophil to the lymphocyte ratio; RDW, red cell distribution width; IL-6, interleukin 6; hs-CRP, high-sensitivity C-reactive protein; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; apoB, apolipoprotein B; apoA1, apolipoprotein A1; apoB/apoA1, the apoB to the apoA1 ratio; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; SYNTAX, SYNergy between Percutaneous Coronary Intervention with TAXus and cardiac surgery; SS, SYNTAX score; SS II, SYNTAX score II; rSS, residual SYNTAX score